Adagene (ADAG) Stock: Buy, Sell, or Hold?
ADAG - Adagene Inc. American Depositary Shares
$3.58
-0.11 (-2.98%)
▼
5d:
-2.72%
30d:
-13.53%
90d:
+7.83%
WAIT
LOW Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Apr 01, 2026
0d
Get Alerted When ADAG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ADAG shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ADAG shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ADAG is currently trading at $3.58, which is considered oversold relative to its 30-day fair value range of $3.64 to $4.03.
Technical Outlook: Technically, ADAG is showing sideways momentum. Immediate support is located at $3.42, while resistance sits at $4.09.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $10.74 (+200.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADAG is showing sideways momentum. Immediate support is located at $3.42, while resistance sits at $4.09.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $10.74 (+200.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.64 -
$4.03
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (59/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 200.0% below Wall St target ($10.74)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.64 -
$4.03
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.42
Resistance Level
$4.09
Current Trend
Sideways
Technical data as of
Sep 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.39
Wall Street Target
$10.74
(+200.0%)
Revenue Growth (YoY)
7332.8%
Profit Margin
-220.8%
Share & Embed Analysis
Last updated: September 06, 2026 2:54 AM ET
Data refreshes hourly during market hours. Next update: 3:54 AM
Data refreshes hourly during market hours. Next update: 3:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADAG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 59 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$370 | 26 SELL |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 40 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
